Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Hikma vice chair invests, Kier executives offload shares

Wed 17 Sep 2025 14:23

(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday. Hikma said executive vice chairman Mazen Darwazah purchased 14,000 shares in the company at a price of 1,603p each, for a total consideration of about £224,418.

The transaction took place on 16 September on the London Stock Exchange.

Separately, Kier said two senior executives sold a combined 600,000 shares the same day.

Chief financial officer Simon Kesterton disposed of 350,000 shares at 203.95p apiece, raising around £713,825.

Group managing director for transportation Giuseppe Incutti meanwhile sold 125,000 shares at 209.51p, 67,500 at 202.79p, and 57,500 at 205.01p, for a total of approximately £516,653.

At 1429 BST, shares in Hikma Pharmaceuticals were up 0.37% at 1,622p, while those in Kier Group were ahead 1.46% at 208.5p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Hikma Pharmaceuticals (HIK) Director name: Darwazah,Mazen Amount purchased: 14,000 @ 1,603.00p Value: £224,420.01

Empire Metals Limited Npv (di) (EEE) Director name: Bunn,Shaun Amount purchased: 40,000 @ 36.50p Value: £14,600.00

Sthree (STEM) Director name: Lehne,Timo Amount purchased: 7,404 @ 139.00p Value: £10,291.56

Eden Research (EDEN) Director name: M. Smith,Sean Amount purchased: 390,624 @ 2.56p Value: £9,999.97

Eden Research (EDEN) Director name: Abrey,Alexander John Amount purchased: 360,490 @ 2.77p Value: £9,985.57

Revolution Beauty Group (REVB) Director name: McDonald,Iain Amount purchased: 333,334 @ 2.95p Value: £9,833.35

Top Director Sells

Kier Group (KIE) Director name: Kesterton,Simon Amount sold: 350,000 @ 203.95p Value: £713,825.00

Bango (BGO) Director name: Anderson, Ray Amount sold: 32,500 @ 101.30p Value: £32,922.50

Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 10,357 @ 40.60p Value: £4,204.94

Share this article

Related Sharecast Articles

Thu 17 Sep 2026 12:11
Director dealings: McBride CFO lowers stake
(Sharecast News) - McBride said on Thursday that chief financial officer Marck Strickland had disposed of 110,000 ordinary shares in the London-listed household goods manufacturer.
Wed 16 Sep 2026 14:56
Director dealings: Hilton Food CEO snaps up shares
(Sharecast News) - Hilton Food Group revealed on Wednesday that chief executive Mark Allen had acquired 14,500 ordinary shares in the FTSE 250-listed food packaging business.
Tue 15 Sep 2026 12:53
Director dealings: Kromek chairman raises stake
(Sharecast News) - Kromek Group revealed on Tuesday that chairman Rakesh Sharma had acquired 145,454 ordinary shares in the AIM-listed global detection firm.
Mon 14 Sep 2026 12:22
Director dealings: Fevertree chairman raises stake
(Sharecast News) - Fevertree Drinks revealed on Monday that chairman Domenic De Lorenzo had acquired 44,674 ordinary shares in the AIM-listed non-alcholic drinksmaker.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026